Key Findings:  Among the participants cannabis was used primarily for motor symptoms associated with PD (63.6%) as well as to treat non-motor symptoms such as anxiety (45.5%), pain (44.0%), and insomnia (44.0%).
Type of Study:  Meta-analysis
Study Sample Size:  1064
Study Result:  Positive
Study Location(s):  United States
Year of Pub:  2019
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified